The robotic surgery monopoly is a poor deal

Abstract

The lack of competition in the surgical robots market may mean that this technology represents a poorer deal than it need do for healthcare buyers—ultimately patients, insurance companies, and taxpayers, write <b>Abhishek Trehan</b> and <b>Tristan J Dunn</b>